keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CTAP(TFA) (103429-32-9 free base) is a potent, highly selective, and brain-penetrant antagonist of the μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP(TFA) (103429-32-9 free base) can be used for the study of L-DOPA-induced dyskinesia (LID)
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 47,000 |
5 mg | 在庫あり | ¥ 118,000 |
10 mg | 在庫あり | ¥ 170,500 |
25 mg | 在庫あり | ¥ 264,000 |
50 mg | 在庫あり | ¥ 356,000 |
100 mg | 在庫あり | ¥ 477,500 |
説明 | CTAP(TFA) (103429-32-9 free base) is a potent, highly selective, and brain-penetrant antagonist of the μ-opioid receptor with IC50 of 3.5 nM. It displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP(TFA) (103429-32-9 free base) can be used for the study of L-DOPA-induced dyskinesia (LID) |
別名 | CTAP(TFA) |
分子量 | 1218.33 |
分子式 | C53H70F3N13O13S2 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CTAP(TFA) (103429-32-9 free base) Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor CTAP(TFA) (103429 32 9 free base) 103429-32-9 free base 103429-32-9 CTAP(TFA) (103429329 free base) CTAP(TFA) CTAP(TFA) Inhibitor inhibitor inhibit